Hospital management company Universal Health Services (NYSE: UHS) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 13.4% year on year to $4.50 billion. The company’s full-year revenue guidance of $17.38 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $5.69 per share was 14.9% above analysts’ consensus estimates.

Is now the time to buy UHS? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Universal Health Services posted third quarter results that exceeded Wall Street’s expectations, leading to a significant positive market reaction. Management attributed this performance to robust acute care hospital activity, improved pricing in both core segments, and the financial benefit from a supplemental Medicaid program in the District of Columbia. CEO Marc Miller specifically highlighted progress at newly opened hospitals in Nevada and Washington, D.C., and noted that operational efficiency and expense management further supported profitability. CFO Steve Filton pointed to a 2% increase in acute care admissions and growth in both inpatient and outpatient services as key factors.

Looking ahead, Universal Health Services’ updated guidance is built on expectations of continued demand in acute care, incremental margin gains, and the expansion of outpatient behavioral health offerings. Management emphasized that the ramp-up of recently opened facilities and disciplined growth in new outpatient access points will be central to driving performance in the coming year. CFO Steve Filton stated, “We believe that further improvements in hiring and capacity utilization, particularly in behavioral health, position us to achieve volume growth targets.” The company is also closely tracking potential changes in Medicaid supplemental payments and payer dynamics as variables that could influence results.

Key Insights from Management’s Remarks

Management credited the quarter’s strong showing to growth in acute care, improved pricing strategies, and the impact of supplemental Medicaid funding while highlighting expansion in outpatient and behavioral services.

• Acute care hospital momentum: Admissions and surgical volumes rose, with CEO Marc Miller noting that both inpatient and outpatient activity contributed to the segment’s performance. Recently opened hospitals, such as West Henderson in Nevada, achieved positive EBITDA soon after launch, which is uncommon for greenfield facilities.
• Supplemental Medicaid impact: The newly approved District of Columbia Medicaid payment program provided a net $90 million benefit, split between acute and behavioral segments, which management expects to collect in the fourth quarter. CFO Steve Filton explained that this program helped offset increased reserves for professional liability and legal settlements.
• Behavioral health trends: While behavioral volumes grew modestly, management reported stable pricing and length of stay, enabled by improved clinical documentation and payer negotiations. Hiring in this segment gradually improved, though labor constraints persist in select markets, limiting capacity in some facilities.
• Outpatient initiative acceleration: Universal Health Services expanded its outpatient footprint, opening additional freestanding emergency departments and step-in behavioral health programs. The company believes these access points are essential for capturing higher acuity outpatient cases and meeting growing demand for community-based behavioral care.
• Capital allocation focus: With limited compelling acquisition opportunities, the board increased the share repurchase authorization by $1.5 billion. Management reiterated its intention to prioritize buybacks and dividends, leveraging strong free cash flow, while maintaining disciplined capital spending on new hospital projects and facility upgrades.

Drivers of Future Performance

Universal Health Services’ outlook centers on sustained acute care demand, margin expansion, and strategic growth in outpatient behavioral services.

• Ramp-up at new facilities: Management expects profitability improvements from recent hospital openings, particularly as Cedar Hill Regional moves toward breakeven and West Henderson continues to mature. These trends are anticipated to support overall margin expansion in 2026.
• Behavioral segment hiring and outpatient growth: The company is targeting 2% to 3% behavioral patient day growth, contingent on continued hiring improvements and the successful rollout of additional outpatient programs. Leadership views the expansion of step-in programs as a pathway to capture more community-based demand and diversify payer mix.
• Supplemental reimbursement and policy risk: Future results hinge partly on the approval and continuation of Medicaid supplemental payment programs, especially in Florida and Nevada. CFO Steve Filton acknowledged ongoing uncertainty regarding government funding and payer policy, which could influence revenue and profit trajectories.

Catalysts in Upcoming Quarters

Looking ahead, our team will watch (1) the ramp-up and profitability at recently opened hospitals, (2) further progress in hiring and capacity utilization within behavioral health, and (3) the rollout and early performance of new outpatient access points—both in acute and behavioral segments. Developments in Medicaid supplemental payment approvals and payer contract negotiations will also be critical.

Universal Health Services currently trades at $217.24, up from $214.06 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free for active Edge members).

Stocks That Trumped Tariffs

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.